Fondaparinux Reduces All Types of Symptomatic Thromboembolic Complications in Patients with Superficial-Vein Thrombosis in the Legs: Data From the CALISTO Study

被引：3
|
作者：
Leizorovicz, Alain [1 ]
Prandoni, Paolo [2 ]
Decousus, Herve [3 ]
机构：
[1] Fac RTH Laennec, Umr 5558, Lyon, France
[2] Univ Hosp Padua, Padua, Italy
[3] Hop Nord St Etienne, Dept Therapeut & Internal Med, INSERM, CIE3 EA3065, St Etienne, France
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
10.1182/blood.V118.21.2310.2310
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1001 / 1001
页数：1
相关论文
共 22 条
  • [21] TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT FOR SYMPTOMATIC PORTAL HYPERTENSION WITH OR WITHOUT PORTAL VEIN THROMBOSIS IN 1,171 PATIENTS WITH CIRRHOSIS: A 14-YEAR RETROSPECTIVE STUDY FROM A SINGLE CENTER
    Lv, Y.
    Zhang, B.
    Guo, W.
    He, C.
    Wang, Z.
    Yin, Z.
    Wang, J.
    Ren, S.
    Meng, X.
    Cai, J.
    Qi, X.
    Bai, M.
    Niu, J.
    Fan, D.
    Han, G.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S659 - S659
  • [22] Ravulizumab reduces the risk of thrombosis in adult patients with paroxysmal nocturnal hemoglobinuria and high disease activity: 2-year data from a Phase 3, open-label study
    Roeth, A.
    de latour, Peffault R.
    Hill, A.
    Fuereder, W.
    Piatek, C.
    Griffin, M.
    Ogawa, M.
    Wang, J.
    Usuki, K.
    Lee, J. W.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 165 - 165
123